Tamoxifen versus tamoxifen + mitoxantrone treatment in metastatic breast cancer.
Kars
A
A
Hacettepe University Institute of Oncology, Ankara, Turkey.
Baltali
E
E
Tekuzman
G
G
Firat
D
D
Alakavuklar
M
M
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D018849:Controlled Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D017698:Postmenopause; D011960:Receptors, Estrogen / Q000032:analysis; D016019:Survival Analysis; D013629:Tamoxifen / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D011960:Receptors, Estrogen; D013629:Tamoxifen; D008942:Mitoxantrone